Celebal Technologies Secures $15M to Advance AI in Energy and Manufacturing Sectors

Celebal Technologies has raised $15 million to develop AI-driven solutions for the energy and manufacturing industries. The funding will support the expansion of their AI capabilities, aiming to enhance operational efficiency and sustainability in these sectors. This investment underscores the growing demand for intelligent automation in traditional industries.

Farmley Raises $40M to Expand Healthy Snacking Reach in India and Abroad

Farmley, a Noida-based D2C healthy snacking brand, has secured $40 million in Series C funding led by L Catterton, with participation from DSG Consumer Partners. The funds will support scaling operations, expanding distribution channels, and enhancing exports. Founded in 2017, Farmley offers a range of snacks like makhana-based munchies and trail mixes, sourcing directly from over 5,000 farmers.

Avammune Secures $12M to Advance Cancer and Autoimmune Therapies

Avammune Therapeutics, a Bengaluru-based healthtech startup, has raised $12 million in a Series A round co-led by Capital 2B, Shastra VC, and Kotak Alternate Asset Managers’ Life Sciences Fund I. The funding will support the clinical development of its lead candidate, AVA-NP-695, an ENPP1 inhibitor, and bolster its IP portfolio. Founded in 2020, Avammune focuses on small molecule therapies targeting the immune system to treat cancer and autoimmune disorders.

M1xchange Raises $10M from Filter Capital to Boost MSME Invoice Financing

M1xchange, an Amazon-backed TReDS platform, secured $10 million (₹84 crore) from Filter Capital via a secondary transaction to enhance its digital supply chain finance operations for MSMEs. Founded in 2017, M1xchange facilitates invoice financing of approximately ₹10,000 crore monthly and has onboarded 50,000 MSMEs, 2,800 corporates, and 66 financial institutions. The company reported a 91% revenue growth to ₹56.47 crore in FY24, while reducing losses by nearly 50% to ₹3.98 crore.

Elizabeth Holmes' Partner Launches Haemanthus, a New Blood-Testing Startup Amid Controversy

Billy Evans, partner of imprisoned Theranos founder Elizabeth Holmes, has initiated a new health-tech venture named Haemanthus. The startup aims to develop AI-driven diagnostic tools using Raman spectroscopy to analyze blood, saliva, and urine samples. Initially focusing on veterinary applications, Haemanthus plans to expand to human diagnostics. Despite Evans' assertions that Holmes has no formal role, reports suggest she is informally advising the project from prison.